Ixchiq Vaccine Pulled From U.S. Market Amid Safety Concerns

(MedPage Today) — Vaccine maker Valneva will pull its chikungunya vaccine (Ixchiq) from the U.S. market after the FDA announced it would take additional steps to investigate the live attenuated shot. The FDA recently put the new experimental test…